Advance Search
ZHOU Yongfeng, DANG Weili. Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 100-102. DOI: 10.7619/jcmp.202014027
Citation: ZHOU Yongfeng, DANG Weili. Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 100-102. DOI: 10.7619/jcmp.202014027
shu

Effect of atorvastatin on vascular function and blood lipid in coronary heart disease patients with percutaneous coronary intervention

  • 1. The First Department of Cardiovascular Diseases, Yulin City Xingyuan Hospital, Yulin, Shaanxi, 719000;

  • 2. Department of Pharmacy, Baoji City Stomatological Hospital, Baoji, Shaanxi, 721001

More Information
  • Received Date: March 21, 2020
    Graphical Abstract
    • Abstract
  • Objective To explore the effect of atorvastatin on vascular endothelial function and blood lipid indexes in coronary heart disease patients with percutaneous coronary intervention(PCI). Methods A total of 90 patients with coronary heart disease after PCI were randomly divided into treatment group and control group, with 45 cases in each group. The control group was treated with conventional drugs for coronary heart disease, and the treatment group was treated with atorvastatin on the basis of the control group. Blood lipid indexes(including high-density lipoprotein, low-density lipoprotein, total cholesterol, triglyceride), vascular endothelial function indexes(vascular endothelial growth factor, nitric oxide)and incidence of adverse cardiovascular events were compared between the two groups before and after treatment. Results The levels of total cholesterol, triglyceride and low density lipoprotein in the treatment group were significantly lower than those in the control group(P<0.05), and the level of high-density lipoprotein was significantly higher than that of the control group(P<0.05). After treatment, the levels of vascular endothelial growth factor and nitric oxide in the treatment group were significantly higher than those in the control group(P<0.05). After treatment, the incidence of adverse cardiovascular events in the treatment group was 6.67%, which was significantly lower than 26.67% in the control group(P<0.05). Conclusion Atorvastatin is safe and effective in the treatment of patients with coronary heart disease after PCI, which can regulate levels of blood lipid indexes and reduce the incidence of adverse cardiovascular events.
    • FullText(HTML)
    • References (17)
  • 张月超. 硫酸氢氯吡格雷片联合阿托伐他汀钙对冠心病PCI术后心绞痛患者血清血脂水平、sCD40L及sICAM-1水平的影响[J]. 标记免疫分析与临床, 2019, 26(7): 1200-1203

    , 1227.
    赵培, 陶金, 袁晓晨, 等. 冠心病患者PCI术后长期高剂量阿托伐他汀治疗的疗效及安全性[J]. 临床心血管病杂志, 2017, 33(3): 226-230.
    符丽珍, 肖孟生. 阿托伐他汀联合丹参川芎嗪对冠心病心肌梗死患者介入治疗后血清胱抑素C、髓过氧化物酶的影响[J]. 现代中西医结合杂志, 2016, 25(19): 2128-2130.
    雷肖蠢, 邱军杰. 不同负荷剂量阿托伐他汀钙对高龄冠心病患者经皮冠状动脉介入术后预后影响的对比研究[J]. 实用心脑肺血管病杂志, 2017, 25(3): 58-61

    , 72.
    杨丽霞, 周玉杰, 王志坚, 等. 老年冠心病患者行经皮冠状动脉介入术术前强化他汀治疗的有效性和安全性研究[J]. 心肺血管病杂志, 2016, 35(3): 170-174.
    周云, 渠乐, 朱小莉, 等. 阿托伐他汀强化治疗对冠脉介入冠心病患者的保护作用研究[J]. 现代生物医学进展, 2016, 16(27): 5317-5320.
    熊小栓, 曾繁芳, 陈娟, 等. 阿托伐他汀序贯疗法对择期PCI治疗患者降脂和抗炎作用的疗效[J]. 心血管康复医学杂志, 2018, 27(4): 440-444.
    景强强, 姚龙. 冠心病患者PCI围术期双倍剂量阿托伐他汀干预的效果及安全性分析简[J]. 中南医学科学杂志, 2016, 44(5): P. 544-547.
    雷斌. 曲美他嗪联合阿托伐他汀对冠心病心绞痛的治疗效果分析[J]. 中国急救医学, 2018, 38(z1): 68-70.
    贾和. 阿托伐他汀钙片对冠心病患者经皮冠状动脉介入术后预后的影响[J]. 实用心脑肺血管病杂志, 2017, 25(S1): 42-44.
    许承志, 朱坤, 王其海, 等. 术前强化他汀治疗对冠心病病人PCI术后心肌标志物及炎性指标的影响[J]. 蚌埠医学院学报, 2017, 42(5): 641-644.
    曹爱华, 李刚, 宋文静. 不同剂量阿托伐他汀对冠心病介入患者调脂、抗炎和安全性研究[J]. 河北医药, 2017, 39(22): 3470-3472.
    张远生, 史丽. 瑞舒伐他汀与阿托伐他汀对冠心病伴高脂血症患者的临床研究[J]. 中国临床药理学杂志, 2019, 35(4): 315-318.
    张可英, 李秀昌. 阿托伐他汀与氟伐他汀对冠心病患者心率变异性的影响[J]. 山东医药, 2016, 56(33): 44-46.
    冯小智. 阿托伐他汀对冠心病患者血脂及内皮脂酶的影响[J]. 实用心脑肺血管病杂志, 2016, 24(4): 110-112.
    吕园园, 刘力, 王志权. 丹参川芎嗪注射液联合阿托伐他汀对冠心病并糖尿病患者血脂、血流变、内皮功能和心功能的影响[J]. 湖北中医药大学学报, 2017, 19(3): 17-20.
    阿荣, 张迎军, 汉迪, 等. 阿托伐他汀对冠心病患者疗效及血清SAA、apoA-Ⅰ、sP-Selectin水平的影响[J]. 检验医学与临床, 2016, 13(23): 3317-3319

    , 3322.
    • Related Articles

  • Related Articles

    [1]ZHANG Shuyuan, HUANG Yongtao, YU Wenjin. Relationship between non-high-density lipoprotein cholesterol and cardiovascular disease in maintenance hemodialysis patients[J]. Journal of Clinical Medicine in Practice, 2025, 29(5): 106-111. DOI: 10.7619/jcmp.20244504
    [2]SUN Mengxiong, YANG Shuai, ZHI Xiongli, YUE Yanjun. Expression and significance of serum complements and blood lipid indexes in patients with coronary heart disease after atorvastatin treatment[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 71-75. DOI: 10.7619/jcmp.20222514
    [3]DENG Junjie, HU Jingxuan, LI Xinghua, LU Yao. Value of small dense low density lipoprotein cholesterol in predicting major adverse cardiovascular events of elderly patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 34-38. DOI: 10.7619/jcmp.20214401
    [4]CHEN Yuchi, LIU Qiang. Correlation between monocyte to high-density lipoprotein cholesterol ratio and carotid artery stenosis in patients with acute cerebral infarction[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 36-39. DOI: 10.7619/jcmp.20201217
    [5]XIN Suping, YE Xinhua. Study on cholesterol in middle-aged and elderly patients with type 2 diabetes mellitus complicated with carotid atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 87-90. DOI: 10.7619/jcmp.202002025
    [6]CHEN Jianbing, CHEN Yinuo, ZHUANG Xiao, FENG Panpan, YANG Fan, WANG Xiang, JI Yue′e, WANG Jinchun. Role of scutellaria baicalensis stem-leaf total flavonoid in regulating blood lipid level of rats with hypertriglyceridemia[J]. Journal of Clinical Medicine in Practice, 2019, 23(21): 70-73. DOI: 10.7619/jcmp.201921021
    [7]XIAO Yuanyuan, HOU Mengling, HE Shenghu. Preliminary study on the changes of residual lipoprotein-cholesterol after three meals in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 6-11. DOI: 10.7619/jcmp.201907003
    [8]MA Qiang, CUI Guoxiong. Effect of atorvastatin combined with trimetazidine on the cardiac function, inflammatory factors and vascular endothelial function in patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2016, (23): 5-8. DOI: 10.7619/jcmp.201623002
    [9]ZHANG Guanzhuang. Correlations between cerebral hemorrhage transformation and total cholesterol, low density lipoprotein and high density lipoprotein[J]. Journal of Clinical Medicine in Practice, 2016, (11): 18-20. DOI: 10.7619/jcmp.201611006
    [10]ZHU Bin, YUAN Daiyue, SHAO Weibin, YAN Dongliang, HAO Qingya. Expression and significance of osteopontin (OPN) protein in gallbladder epithelium of patients with cholesterol gallstone[J]. Journal of Clinical Medicine in Practice, 2013, (17): 27-28,35. DOI: 10.7619/jcmp.201317008

  • Cited by

    Periodical cited type(5)

    1. 张利玲，安昱静，张肖，齐鹏，黄倩倩. 妊娠糖尿病患者血清LRG1和CCL2水平对产后血糖转归的预测价值. 临床和实验医学杂志. 2024(11): 1192-1196 .
    2. 刁瑞萍，李延伟，赵静超，李燕. 子痫前期孕妇血清circRNA VRK1表达水平与临床指标的相关性及对妊娠结局的预测价值. 中国计划生育和妇产科. 2023(06): 55-59 .
    3. 王巍，高素芳，高莉. miR-377对子痫前期胎盘滋养层细胞HTR-8/SVneo凋亡和氧化应激的影响及MAPK/ERK信号通路在其中的作用. 中国妇幼保健. 2023(16): 3103-3108 .
    4. 曾莉芳. 硝苯地平联合拉贝洛尔治疗子痫前期患者对胎儿血流动力学及母婴结局的影响. 中国现代药物应用. 2022(22): 44-47 .
    5. 黄玮，王旭，沈志梅，崔飞. 基质细胞衍生因子-1在骨质疏松中的作用机制研究进展. 实用临床医药杂志. 2022(21): 144-148 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (431) PDF downloads (11) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return